These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 6430367)

  • 1. Haemophilia due to factor VIII inhibitors in a patient suffering from an autoimmune disease: treatment with intravenous immunoglobulin. A case report.
    Gianella-Borradori A; Hirt A; Lüthy A; Wagner HP; Imbach P
    Blut; 1984 Jun; 48(6):403-7. PubMed ID: 6430367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acquired hemophilia in the patient suffering from rheumatoid arthritis: case report.
    Drobiecki A; Pasiarski M; Hus I; Sokołowska B; Wątek M
    Blood Coagul Fibrinolysis; 2013 Dec; 24(8):874-80. PubMed ID: 24042266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The treatment of haemophilia A inhibitor with high dose intravenous immunoglobulin.
    Seifried E; Gaedicke G; Pindur G; Rasche H
    Blut; 1984 Jun; 48(6):397-401. PubMed ID: 6430366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitor to factor VIII in mild haemophilia.
    Kesteven PJ; Holland LJ; Lawrie AS; Savidge GF
    Thromb Haemost; 1984 Aug; 52(1):50-2. PubMed ID: 6437010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recommendations for the treatment of factor VIII inhibitors: from the UK Haemophilia Centre Directors' Organisation Inhibitor Working Party.
    Hay CR; Colvin BT; Ludlam CA; Hill FG; Preston FE
    Blood Coagul Fibrinolysis; 1996 Mar; 7(2):134-8. PubMed ID: 8735802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune thrombocytopenia in severe hemophilia A treated with high-dose intravenous immunoglobulin.
    Panzer S; Zeitelhuber U; Hach V; Brackmann HH; Niessner H; Mueller-Eckhardt C
    Transfusion; 1986; 26(1):69-72. PubMed ID: 3080831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-idiotypic suppression of autoantibodies to factor VIII (antihaemophilic factor) by high-dose intravenous gammaglobulin.
    Sultan Y; Kazatchkine MD; Maisonneuve P; Nydegger UE
    Lancet; 1984 Oct; 2(8406):765-8. PubMed ID: 6148519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acquired hemolytic anemia and thrombocytopenia (Evans' syndrome) in hemophilia.
    Harris PJ; Kessler CM; Lessin LS
    N Engl J Med; 1983 Jul; 309(1):50. PubMed ID: 6406894
    [No Abstract]   [Full Text] [Related]  

  • 9. [Massive bleeding episodes in patients with acquired haemophilia--case report].
    Sokołowska B; Tomczak W; Gromek T; Legieć W
    Pol Arch Med Wewn; 2006 Apr; 115(4):351-5. PubMed ID: 17078494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Domiciliary desensitization therapy for young boys with haemophilia and factor VIII inhibitors.
    Lilleyman JS
    Br J Haematol; 1994 Feb; 86(2):433-5. PubMed ID: 8199043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An inhibitor to factor VIII:C in a patient with possible combined haemophilia A and von Willebrand's disease.
    Taylor LD; Dean FL; Tiedemann K; Ekert H
    Thromb Haemost; 1986 Apr; 55(2):158-61. PubMed ID: 3087000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracranial haemorrhage in a boy with severe haemophilia A and factor VIII inhibitor.
    Laguna P; Klukowska A
    Childs Nerv Syst; 2006 Apr; 22(4):432-5. PubMed ID: 15928966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunosuppressive treatment of a spontaneous inhibitor hemophilia A using cyclophosphamide, vincristine and prednisone following prior Factor VIII stimulation].
    Dürig J; de Wit M; Fiedler W; Marx G; Hossfeld DK
    Schweiz Med Wochenschr; 1996 Nov; 126(47):2026-31. PubMed ID: 8984611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous infusion of porcine factor VIII in the management of patients with factor VIII inhibitors.
    Rubinger M; Houston DS; Schwetz N; Woloschuk DM; Israels SJ; Johnston JB
    Am J Hematol; 1997 Oct; 56(2):112-8. PubMed ID: 9326353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Factor VIII inhibitors--their characteristics and clinical significance].
    Dmoszyńska A; Kniaź M; Sokołowska B
    Pol Arch Med Wewn; 1987 Dec; 78(6):333-40. PubMed ID: 3152083
    [No Abstract]   [Full Text] [Related]  

  • 16. Suppression of inhibitors in haemophilia with corticoids and factor VIII.
    Aznar JA; Jorquera JI; Peiro A
    Thromb Haemost; 1983 Jun; 49(3):248. PubMed ID: 6410535
    [No Abstract]   [Full Text] [Related]  

  • 17. [Combined treatment with factor VIII and immunosuppressive agents in a young woman with acquired factor VIII inhibitor].
    José Aguado M; Carrasco V; Periago A; Bello T; González E; García-Talavera J
    Sangre (Barc); 1996 Apr; 41(2):147-50. PubMed ID: 9045356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-idiotypes to factor VIII antibodies and their possible role in the pathogenesis and treatment of factor VIII inhibitors.
    Moffat EH; Furlong RA; Dannatt AH; Bloom AL; Peake IR
    Br J Haematol; 1989 Jan; 71(1):85-90. PubMed ID: 2492821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factor VIII antibody in a patient with mild haemophilia.
    Bovill EG; Burns SL; Golden EA
    Br J Haematol; 1985 Oct; 61(2):323-8. PubMed ID: 3929830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epsilon-aminocaproic acid inhibits the activity of factor VIII inhibitors in patients with severe haemophilia A in vivo and in vitro.
    Ghosh K; Shetty S; Pathare A; Mohanty D
    Acta Haematol; 2000; 103(2):67-72. PubMed ID: 10838448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.